We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
The current LFCR market cap is 219.93M. The company's latest EPS is USD 0.3245 and P/E is 27.00.
| Quarter End | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 | Nov 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 30.15M | 35.7M | 37.89M | 24.71M | 32.56M |
| Operating Income | -1.47M | -896k | 2.15M | -11.58M | -1.96M |
| Net Income | 14.22M | 15.63M | -7.08M | -16.23M | -8.7M |
| Year End 26 May 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 590.37M | 544.16M | 185.79M | 105.38M | 128.26M |
| Operating Income | -38.54M | -13.5M | -41.29M | -21.8M | -8.84M |
| Net Income | -38.19M | -32.67M | -97.43M | -99.56M | 12.01M |
| Quarter End | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 | Nov 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 245.82M | 246.24M | 253.96M | 246.82M | 255.39M |
| Total Liabilities | 203.47M | 186.81M | 200.06M | 207.32M | 195.63M |
| Total Equity | 1.42M | 17.69M | 11.32M | -3.94M | 15.45M |
| Year End 26 May 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 541.31M | 502.92M | 295.16M | 253.55M | 253.96M |
| Total Liabilities | 310.27M | 300.14M | 187.22M | 218.46M | 200.06M |
| Total Equity | 231.04M | 202.78M | 107.95M | -4.23M | 11.32M |
| Quarter End | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 | Nov 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.32M | -8.86M | -217k | -643k | -6.75M |
| Investing | -9.03M | -15.28M | -17.92M | -3.39M | -5.86M |
| Financing | 486k | 8.12M | 7.51M | 1.09M | 13.61M |
| Year End 26 May 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.04M | 15.02M | -24.3M | -17.44M | -217k |
| Investing | -23.89M | -10.86M | 81.77M | -4.81M | -17.92M |
| Financing | 40.02M | -3.42M | -57.02M | 39.7M | 7.51M |
| Market Cap | 219.93M |
| Price to Earnings Ratio | 27.00 |
| Price to Sales Ratio | 2.53 |
| Price to Cash Ratio | 38.34 |
| Price to Book Ratio | 6.02 |
| Dividend Yield | - |
| Shares Outstanding | 37.03M |
| Average Volume (1 week) | 180.17k |
| Average Volume (1 Month) | 289.72k |
| 52 Week Change | -11.48% |
| 52 Week High | 8.90 |
| 52 Week Low | 3.6793 |
| Spread (Intraday) | 5.36 (48.91%) |
| Company Name | Lifecore Biomedical Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.lifecore.com |
| Industry | plastics,resins,elastomers (2821) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
